Skip to Content
Merck
All Photos(2)

Documents

358894

Sigma-Aldrich

O-Tritylhydroxylamine

95%

Synonym(s):

O-(Triphenylmethyl)hydroxylamine, Trityloxyamine

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
(C6H5)3CONH2
CAS Number:
31938-11-1
Molecular Weight:
275.34
Beilstein:
1983917
EC Number:
250-868-1
MDL number:
MFCD00042818
UNSPSC Code:
12352100
PubChem Substance ID:
24862034
NACRES:
NA.22

Assay

95%

mp

79-81 °C (lit.)

SMILES string

NOC(c1ccccc1)(c2ccccc2)c3ccccc3

InChI

1S/C19H17NO/c20-21-19(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H,20H2

InChI key

NZFHJBSDSXDUAO-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

O-Tritylhydroxylamine may be used in the preparation of 8-azido-O-trityloctahydroxamate and 9-azido-O-tritylnonahydroxamate. It may be used in the synthesis of Simian virus nuclear localization peptide (NLS)-histone deacetylase (HDAC) inhibitor conjugates.

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Vishal Patil et al.
Bioorganic & medicinal chemistry, 18(1), 415-425 (2009-11-17)
Histone deacetylase inhibitors (HDACi) are endowed with plethora of biological functions including anti-proliferative, anti-inflammatory, anti-parasitic, and cognition-enhancing activities. Parsing the structure-activity relationship (SAR) for each disease condition is vital for long-term therapeutic applications of HDACi. We report in the present
Joshua C Canzoneri et al.
Bioorganic & medicinal chemistry letters, 19(23), 6588-6590 (2009-10-27)
We describe herein the synthesis and characterization of a new class of histone deacetylase (HDAC) inhibitors derived from conjugation of a suberoylanilide hydroxamic acid-like aliphatic-hydroxamate pharmacophore to a nuclear localization signal peptide. We found that these conjugates inhibited the histone
Francisco J Prado-Prado et al.
Bioorganic & medicinal chemistry, 18(6), 2225-2231 (2010-02-27)
There are many of pathogen parasite species with different susceptibility profile to antiparasitic drugs. Unfortunately, almost QSAR models predict the biological activity of drugs against only one parasite species. Consequently, predicting the probability with which a drug is active against

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service